TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,408,170 shares
Latest Disclosed Value $ 46,779,474
Morgan Stanley reports 6.31% decrease in ownership of 1TGTX / TG Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,408,170 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $38,949,982 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,503,037 shares of TG Therapeutics, Inc.. This represents a change in shares of -6.31% during the quarter. The current value of the position is $47,877,780 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 1,408,170 -94,867 -6.31 46,779 4.41 0.0028
2026-05-27 2025-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,503,037 255,236 20.45 44,806 -0.60 0.0027
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 1,503,037 255,236 44,806 0.0027
2026-05-27 2025-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,247,801 -154,812 -11.04 45,077 -10.71 0.0027
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 1,247,801 -154,812 45,077 0.0027
2025-08-15 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 1,402,613 -647,935 -31.60 50,480 -37.57 0.0033
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 2,050,548 -113,886 -5.26 80,853 24.10 0.0058
2025-05-15 2024-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 2,164,434 -34 -0.00 65,149 28.69 0.0046
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 2,164,434 -34 65,149 0.0046
2025-05-14 2024-09-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 2,164,468 675,726 45.39 50,627 91.16 0.0037
2025-02-14 2024-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 2,164,468 675,726 50,627 0.0037
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 2,164,468 675,726 50,627 0.0037
2025-05-14 2024-06-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 1,488,742 317,005 27.05 26,485 48.60 0.0020
2024-10-17 2024-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,488,742 317,005 26,485 0.0020
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 1,488,742 317,005 26,485 0.0020
2024-10-17 2024-03-31 13F/A-2 TG THERAPEUTICS COM 88322Q108 1,171,737 -317,746 -21.33 17,822 -29.94 0.0014
2024-08-16 2024-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,171,737 -317,746 17,822 0.0014
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 1,171,737 -317,746 17,822 0.0014
2024-08-16 2023-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,489,483 -387,197 -20.63 25,440 62.15 0.0022
2024-02-13 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 1,489,483 -387,197 25,440 0.0022
2023-11-15 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 1,876,680 186,498 11.03 15,689 -62.63 0.0016
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 1,690,182 417,406 32.79 41,984 119.33 0.0041
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 1,272,776 498,536 64.39 19,143 109.00 0.0021
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 774,240 397,442 105.48 9,159 310.72 0.0010
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 376,798 -1,522,212 -80.16 2,230 -72.37 0.0003
2022-10-27 2022-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,899,010 810,658 74.48 8,071 -22.03 0.0010
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 1,899,010 810,658 8,071 0.0010
2022-10-27 2022-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 1,088,352 522,110 92.21 10,352 -3.77 0.0014
2022-05-13 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 1,088,352 522,110 10,352 0.0014
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 566,242 -113,956 -16.75 10,758 -52.48 0.0013
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 680,198 379,122 125.92 22,637 93.84 0.0030
2021-08-23 2021-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 301,076 237,714 375.17 11,678 282.51 0.0015
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 301,076 237,714 11,678 0.0003
2021-05-17 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 63,362 -190,548 -75.05 3,053 -76.89 0.0004
2021-02-16 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 253,910 113,779 81.19 13,209 252.33 0.0020
2020-11-13 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 140,131 -22,137 -13.64 3,749 18.60 0.0007
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 162,268 -151,163 -48.23 3,161 2.46 0.0007
2020-05-26 2020-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 313,431 1,968 0.63 3,085 -10.76 0.0008
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 313,431 1,968 3,085 236.9923
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 311,463 92,575 42.29 3,457 181.51 0.0008
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 218,888 108,168 97.70 1,228 28.18 0.0003
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 110,720 33,903 44.13 958 55.02 0.0003
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 76,817 -577,508 -88.26 618 -76.97 0.0002
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 654,325 476,531 268.02 2,683 169.38 0.0008
2019-04-23 2018-09-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 177,794 -69,059 -27.98 996 -69.32 0.0002
2018-11-20 2018-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 177,794 0 996 0.0002
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 177,794 -69,059 996
2019-04-23 2018-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 246,853 88,737 56.12 3,246 44.59 0.0009
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 246,853 88,737 3,246
2019-04-23 2018-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 158,116 -21,461 -11.95 2,245 52.51 0.0006
2018-05-14 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 158,116 -21,461 2,245
2019-04-23 2017-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 179,577 77,089 75.22 1,472 21.25 0.0004
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 179,577 77,089 1,472
2017-11-14 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 102,488 -1,915 -1.83 1,214 15.73 0.0004
2017-08-11 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 104,403 -57 -0.05 1,049 -13.80 0.0003
2017-05-22 2017-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 104,460 -20,310 -16.28 1,217 109.83 0.0004
2017-05-12 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 104,460 1,217
2017-02-22 2016-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 124,770 21,397 20.70 580 -27.59 0.0002
2017-02-13 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 124,770 580
2016-11-10 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 103,373 52,491 103.16 801 159.22 0.0003
2016-08-12 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 50,882 -20,703 -28.92 309 -49.34 0.0001
2016-05-12 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 71,585 25,107 54.02 610 9.91 0.0002
2016-02-09 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 46,478 -11,447 -19.76 555 -4.80 0.0002
2016-02-08 2015-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 57,925 -1,615 -2.71 583 -40.99 0.0002
2015-11-09 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 57,925 583
2015-08-12 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 59,540 -15,387 -20.54 988 -14.90 0.0003
2015-05-14 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 74,927 4,755 6.78 1,161 4.41 0.0004
2015-02-13 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 70,172 50,372 254.40 1,112 424.53 0.0004
2014-12-16 2014-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 19,800 -91,638 -82.23 212 -72.43 0.0001
2014-11-14 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 19,800 212
2014-05-13 2014-03-31 13F TG THERAPEUTICS COM 88322Q108 111,438 109,799 6,699.15 769 12,716.67 0.0003
2014-02-13 2013-12-31 13F TG THERAPEUTICS COM 88322Q108 1,639 -31,341 -95.03 6 -97.16 0.0000
2013-08-08 2013-06-30 13F TG THERAPEUTICS INC COM STK COM 88322Q108 32,980 32,980 211 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.